Collagen binding provides a sensitive screen for variant von Willebrand disease.
about
Diagnostic approach to von Willebrand diseaseCrucial role for the VWF A1 domain in binding to type IV collagen.Rapid discrimination of the phenotypic variants of von Willebrand disease.Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis.Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.An update on type 2B von Willebrand disease.Acquired von Willebrand syndrome in a child following Berlin Heart EXCOR Pediatric Ventricular Assist Device implantation: case report and concise literature review.Developments in the diagnostic procedures for von Willebrand disease.A diagnostic approach to mild bleeding disorders.Current and emerging approaches for assessing von Willebrand disease in 2016.Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease.Clinical and laboratory phenotype variability in type 2M von Willebrand disease.A comparative evaluation of a new fully automated assay for von Willebrand factor collagen binding activity to an established method.Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels.Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF.Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.
P2860
Q35220634-2DBECC6C-4200-4B8D-B3D7-ED22D5292A75Q35252688-FCD68D01-A435-4503-B09A-BB272C219813Q36920458-DE365491-7E98-45F3-9782-D0D7B03C1568Q37012522-1894AFE0-49B1-411E-8B2A-F050DE723968Q37703427-FB203887-3C9F-4EF4-9BB7-815F9FE6A7A6Q38187477-8B3564B3-1ABD-4515-B8A2-B4902190D083Q38260983-F03A78F3-25E1-4166-A7FF-B1C612361523Q38682256-C75E03C1-9D1A-40FE-A915-D9B64B5A0CEEQ38840603-DDD253CA-ECAC-4145-A872-3769262A4B5DQ38900004-A017D24A-E588-48A9-BFFC-87F304CB4275Q38953188-DAA17B09-3D2F-458A-A708-A03CB9F5A67DQ45868176-DA17F42C-27C3-46B3-A7A4-62A395EEF924Q45874913-2740DF13-57C2-4EC9-AB67-3158088B7C7BQ47416217-E7189FFD-ECC3-4130-BE26-5341F6343C29Q48239727-28EAF0C0-26B3-4D78-BEF7-72D9CD9C9ADFQ55431354-F84C2C7F-E592-45D1-A34D-3EA2EB28733B
P2860
Collagen binding provides a sensitive screen for variant von Willebrand disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Collagen binding provides a sensitive screen for variant von Willebrand disease.
@en
Collagen binding provides a sensitive screen for variant von Willebrand disease.
@nl
type
label
Collagen binding provides a sensitive screen for variant von Willebrand disease.
@en
Collagen binding provides a sensitive screen for variant von Willebrand disease.
@nl
prefLabel
Collagen binding provides a sensitive screen for variant von Willebrand disease.
@en
Collagen binding provides a sensitive screen for variant von Willebrand disease.
@nl
P2093
P2860
P1433
P1476
Collagen binding provides a sensitive screen for variant von Willebrand disease.
@en
P2093
Joan Cox Gill
Kenneth D Friedman
Pamela A Christopherson
Paula M Jacobi
Raymond G Hoffmann
Robert R Montgomery
Sandra L Haberichter
Veronica H Flood
Zimmerman Program Investigators
P2860
P304
P356
10.1373/CLINCHEM.2012.199000
P407
P577
2013-01-22T00:00:00Z